{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-207129","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2024-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.474706+00:00","generated_at":"2026-05-31T07:46:58.728890+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CEO John Bencich departs; Richard Stewart named CEO, Thomas King Executive Chairman","bullets":["John Bencich removed as CEO effective Aug 21, 2024; receives lump-sum severance of 18-month base salary and accelerated equity vesting.","Richard Stewart, previously Executive Chairman, appointed CEO effective Aug 21; base salary $615K, annual bonus up to 50%, 157,500 performance RSUs and 67,500 stock options.","Thomas King appointed Executive Chairman; base salary $495K, option for 195,000 shares, 455,000 performance RSUs.","King steps down from Compensation, Audit, and Nominating committees; Thomas Sellig appointed Compensation Committee Chair."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-207129","json":"https://secwatch.observer/filing/0001193125-24-207129.json","markdown":"https://secwatch.observer/filing/0001193125-24-207129.md","text":"https://secwatch.observer/filing/0001193125-24-207129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000119312524207129/0001193125-24-207129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000119312524207129/d834963d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:46:58.728890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d99321bc77","claim":"Richard Stewart was appointed as Chief Executive Officer at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"the Board of Directors of the Company (the “ Board ”) appointed Richard Stewart as the Company’s Chief Executive Officer, “principal executive officer” and “principal financial officer.”","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312524207129/0001193125-24-207129-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"da442e2942","claim":"John Bencich resigned as Chief Executive Officer at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"determined that John Bencich will no longer serve as the Company’s Chief Executive Officer, “principal executive officer” or “principal financial officer,” effective as of August 21, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312524207129/0001193125-24-207129-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}